naltrexone

(redirected from Vivitrol)
Also found in: Dictionary, Thesaurus, Encyclopedia.
Related to Vivitrol: Suboxone

naltrexone

 [nal-trek´sōn]
an opioid antagonist used as the hydrochloride salt in treatment of opioid or alcohol abuse.
Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health, Seventh Edition. © 2003 by Saunders, an imprint of Elsevier, Inc. All rights reserved.

nal·trex·one

(nal-treks'ōn),
An orally active narcotic antagonist; devoid of pharmacologic action when administered in the absence of narcotics.
Farlex Partner Medical Dictionary © Farlex 2012

naltrexone

(năl-trĕk′sōn)
n.
A synthetic opioid antagonist, C20H23NO4, used in its hydrochloride form to treat addiction to alcohol and to opioid drugs such as heroin.
The American Heritage® Medical Dictionary Copyright © 2007, 2004 by Houghton Mifflin Company. Published by Houghton Mifflin Company. All rights reserved.

naltrexone

Substance abuse An opioid antagonist used to manage opiate, alcohol and other abuse substances; naltrexone binds to endorphin receptors, preventing endophin receptor binding, reducing the craving for abuse substances. See Cocaine. Cf Antabuse.
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.

naltrexone

A narcotic antagonist used as a maintenance therapy in former narcotic addicts. A brand name is Nalorex.
Collins Dictionary of Medicine © Robert M. Youngson 2004, 2005

nal·trex·one

(nal-treks'ōn)
Orally active narcotic antagonist; devoid of pharmacologic action when administered in absence of narcotics.
Medical Dictionary for the Dental Professions © Farlex 2012
References in periodicals archive ?
Our doctors have since moved in the direction of using Suboxone for opiate addiction as a short-term tapering replacement therapy and using Vivitrol on an ongoing basis.
Approved by the Food and Drug Administration (FDA) in 2006, Vivitrol is an injectable form of the drug naltrexone that stays in the body for 30 days.
Patent Number 7,919,499 ('499 Patent), an Orange Book-listed patent for VIVITROL (naltrexone for extended-release injectable suspension) that expires in 2029.
Unlike Suboxone, people who take extended-release antagonists like Vivitrol must complete detoxification first.
As for extended-release naltrexone (Vivitrol), the pivotal double-blind Russian trial that won Food and Drug Administration approval for treatment of OUD showed a dramatic improvement in opioid-free weeks (Lancet.
M2 PHARMA-August 31, 2018-UPMC Health Plan signs value-based contract with Alkermes for VIVITROL for opioid addiction
M2 EQUITYBITES-August 31, 2018-UPMC Health Plan signs value-based contract with Alkermes for VIVITROL for opioid addiction
Global Banking News-August 31, 2018-UPMC Health Plan signs value-based contract with Alkermes for VIVITROL for opioid addiction
"MAT is not only the use of one of the three FDA-approved medications -- methadone, buprenorphine and vivitrol, but also the use of behavior therapy and many supportive services for the individual person in need.
As for extended-release naltrexone (Vivitrol), the pivotal double-blind Russian trial that helped it win FDA approval for treatment of OUD showed a dramatic improvement in opioid-free weeks (Lancet.
One is the use of three medications to treat opioid addiction: methadone, buprenorphine and Vivitrol.